The Vcanbio-backed cancer diagnostics technology provider has filed to go public in the US having raised another $71m from investors including Alexandria Venture Investments.
China-based oncology diagnostics technology provider Genetron Holdings filed for a $100m initial public offering yesterday, closing a RMB500m ($71m) round featuring real estate investment trust Alexandria Real Estate Equities the same day.
Alexandria co-led the round through its Alexandria Venture Investments vehicle with Vivo Capital and CICC Healthcare Investment Fund, while Highlight Capital and unnamed existing backers also took part, according to an announcement reported by DealStreetAsia.
Founded in 2015, Genetron has developed molecular profiling technology it uses for…
